4,6-Dimethylisoxazolo[5,4-b]pyridin-3-amine, 97%, 250mg

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95%, 5g

1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-2,2,2-trichloroethanone, 98%, 250mg

(S)-(-)-1-Phenyl-propan-1-ol, 98.0%, 1g

5-(Difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic acid, 100mg

2-Methyl-4-nitropyridine, 95.0%, 100g

N-cyclopropyl-N-(piperidin-4-yl)methanesulfonamide, 95.0%, 500mg

6-Hydroxynicotinic acid, 98.0%, 25g

Tungsten acid, min. 99%, pa, 25 g, plastic packaging.

2-Chlorobenzene-1,3,5-triol, 97.0%, 1g

Oxazol-2-ylmethylamine hydrochloride, 97.0%, 5g

4-Nitrophenylacetic acid, 95.0%, 1kg

Ethyl 2-(2-fluoro-phenoxy)acetate, 97.0%, 25g